Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, and Marco Corigliano. “Short-Term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience”. Heart Research 4, no. 3 (July 28, 2017): 46–56. Accessed November 14, 2026. https://openventio.us/index.php/HROJ/article/view/816.